TYPE 2 DIABETES PATIENTS SUBCLASSIFICATION ANALYSIS: PERSONALIZED T2D CARE OF DORZAGLIATIN

Feng, L; Chen, C; Chen, L

DIABETES TECHNOLOGY & THERAPEUTICS, 2023; 25 (): A87